CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for OCTAPHARMA USA, INC. · Pharmaceuticals

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 3

Trade (domestic/foreign)

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Medical/Disease Research/Clinical Labs

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Manufacturing

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.